The Center for Technology Licensing (CTL) is Cornell University's technology transfer office. We manage technology for Cornell's Ithaca campus, Weill Cornell Medicine, Cornell Tech, and Cornell AgriTech in Geneva.


The Center for Technology Licensing’s mission is to bring the University's scientific discoveries, technological innovations, and medical advances to the marketplace for societal benefit and to foster economic development within New York State and across the nation. Below is a selection of technologies developed at Cornell and managed by CTL. For more information about these and other innovations available for licensing, please e-mail


Fruit & Vegetable Markets Webinar

Join us for a panel discussion on the impacts of COVID-19 on the fruit and vegetable markets across the U.S.A. and specifically in New York State.

Women Innovators Initiative (WI2) #3

For the third WI2 webinar, we speak with two women founders and CEOs from Cornell University to find out about their experience as female founders/CEOs and to hear about the lessons learned during the formation and the growth of their venture.

Blood-Brain Barrier Blood-Brain Barrier, Protecting the Brain

After Margaret Bynoe and her lab discovered that an FDA-approved drug, Lexiscan, used in cardiac imaging, could open the blood-brain barrier, the lab went to work, exploring how it could be used as a therapeutic for brain diseases.

DNA illustration Mobile Gene Content

Ilana L. Brito and her team are developing a suite of computational tools for examining the mobile gene content in multiple datasets — to identify those genes that may shape the response of microbial communities to stress.

Emin Gün Sirer Tackling Cyberfinance Security

Emin Gün Sirer’s research group developed and tested Falcon — which they call fast and fierce — for processing Bitcoin blockchains, digital transaction ledgers.

Holger Sondermann lab The Lifestyle of Bacteria

When bacteria live in a community known as biofilm, antibiotics can’t enter to fight infection. Holger Sondermann wants to disperse that community.

Peng Chen single-molecule imaging Innovating with Single-Molecule Imaging

As a pioneer of single-molecule imaging, Peng Chen applies the technology to studying metal atoms in cells, with implications for the development of antibacterial agents.


Hening Lin Sirtuins: New Understanding, New Inhibitors, and New Applications

Dr. Hening Lin is an Investigator in the Howard Hughes Medical Center and Professor of Chemistry and Chemical Biology at Cornell University. Dr. Lin’s understanding of sirtuin enzymatic activity has enabled the development of a potent sirtuin2-specific inhibitor called “TM.”

Benedict Law Peptide-Based Nanofibers

Dr. Benedict Law is an Assistant Professor of Pharmacology in Radiology at Weill Cornell Medicine. Dr. Law’s team is interested in a new type of two-dimensional nanomaterial, such as nanofiber (PF) that is biocompatible, able to penetrate inside a tumor, and has a short circulation time to avoid non-specific in vivo distribution with a high tumor uptake.

Rob Shepherd Soft Robotics for AR/VR

Dr. Robert Shepherd, Assistant Professor of Mechanical and Aerospace Engineering, and his team have developed foam actuators and sensors to create soft robotics that are safe for use in prosthetics and enhance augmented and virtual reality experiences.

Paul Steen Switchable Adhesion Device

Paul Steen, Professor in Chemical and Biomolecular Engineering, has developed a switchable electronically- controlled adhesion device that allows for maximum adhesion to various surfaces. Among the applications for the device are wafer handling, large-format printing, gripping gloves and shoes, and drone parking pods.